Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Bick

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Seminars in Thrombosis and Hemostasis|October 1, 1982
Clinical relevance of antithrombin IIIR L Bick
Seminars in Thrombosis and Hemostasis|October 1, 1982
The clinical significance of fibrinogen degradation productsR L Bick
American Journal of Clinical Pathology|November 1, 1993
The antiphospholipid-thrombosis syndromes. Fact, fiction, confusion, and controversyR L Bick
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2000
Recurrent miscarriage syndrome due to blood coagulation protein/platelet defects: prevalence, treatment and outcome results. DRW Metroplex Recurrent Miscarriage Syndrome Cooperative GroupR L Bick
Hematology/Oncology Clinics of North America|September 27, 2000
Syndromes of disseminated intravascular coagulation in obstetrics, pregnancy, and gynecology. Objective criteria for diagnosis and managementR L Bick
Hematology/Oncology Clinics of North America|September 27, 2000
Recurrent miscarriage syndrome and infertility caused by blood coagulation protein or platelet defectsR L Bick
Drugs|October 13, 2000
Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolismR L Bick
The Medical Clinics of North America|May 1, 1994
Disseminated intravascular coagulation. Objective criteria for diagnosis and managementR L Bick
The Medical Clinics of North America|May 1, 1994
Platelet function defects associated with hemorrhage or thrombosisR L Bick
Clinics in Laboratory Medicine|March 1, 1995
Laboratory evaluation of platelet dysfunctionR L Bick
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Seminars in Thrombosis and Hemostasis|October 1, 1982
Clinical relevance of antithrombin IIIR L Bick
Seminars in Thrombosis and Hemostasis|October 1, 1982
The clinical significance of fibrinogen degradation productsR L Bick
American Journal of Clinical Pathology|November 1, 1993
The antiphospholipid-thrombosis syndromes. Fact, fiction, confusion, and controversyR L Bick
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2000
Recurrent miscarriage syndrome due to blood coagulation protein/platelet defects: prevalence, treatment and outcome results. DRW Metroplex Recurrent Miscarriage Syndrome Cooperative GroupR L Bick
Hematology/Oncology Clinics of North America|September 27, 2000
Syndromes of disseminated intravascular coagulation in obstetrics, pregnancy, and gynecology. Objective criteria for diagnosis and managementR L Bick
Hematology/Oncology Clinics of North America|September 27, 2000
Recurrent miscarriage syndrome and infertility caused by blood coagulation protein or platelet defectsR L Bick
Drugs|October 13, 2000
Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolismR L Bick
The Medical Clinics of North America|May 1, 1994
Disseminated intravascular coagulation. Objective criteria for diagnosis and managementR L Bick
The Medical Clinics of North America|May 1, 1994
Platelet function defects associated with hemorrhage or thrombosisR L Bick
Clinics in Laboratory Medicine|March 1, 1995
Laboratory evaluation of platelet dysfunctionR L Bick
Pageof 12